Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10091312rdf:typepubmed:Citationlld:pubmed
pubmed-article:10091312lifeskim:mentionsumls-concept:C0032961lld:lifeskim
pubmed-article:10091312lifeskim:mentionsumls-concept:C0733755lld:lifeskim
pubmed-article:10091312lifeskim:mentionsumls-concept:C1555558lld:lifeskim
pubmed-article:10091312lifeskim:mentionsumls-concept:C0521116lld:lifeskim
pubmed-article:10091312pubmed:issue1lld:pubmed
pubmed-article:10091312pubmed:dateCreated1999-7-6lld:pubmed
pubmed-article:10091312pubmed:abstractTextThe reduction of vertical transmission rates in Germany to 5-7% is basically due to antiretroviral therapy during pregnancy with zidovudine and elective caesarean section after 37 weeks of gestation. Maternal versus fetal needs have to be considered carefully in respect to mode of delivery and antiretroviral therapy. Long term consequences for the fetus of antiretroviral therapy are not yet sufficiently known.lld:pubmed
pubmed-article:10091312pubmed:languagegerlld:pubmed
pubmed-article:10091312pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10091312pubmed:citationSubsetIMlld:pubmed
pubmed-article:10091312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10091312pubmed:statusMEDLINElld:pubmed
pubmed-article:10091312pubmed:issn0044-4197lld:pubmed
pubmed-article:10091312pubmed:authorpubmed-author:FunkeA MAMlld:pubmed
pubmed-article:10091312pubmed:issnTypePrintlld:pubmed
pubmed-article:10091312pubmed:volume121lld:pubmed
pubmed-article:10091312pubmed:ownerNLMlld:pubmed
pubmed-article:10091312pubmed:authorsCompleteYlld:pubmed
pubmed-article:10091312pubmed:pagination33-4lld:pubmed
pubmed-article:10091312pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:meshHeadingpubmed-meshheading:10091312...lld:pubmed
pubmed-article:10091312pubmed:year1999lld:pubmed
pubmed-article:10091312pubmed:articleTitle[Current position on the care of HIV-seropositive pregnancies].lld:pubmed
pubmed-article:10091312pubmed:affiliationUniversitäts-Frauenklinik Köln.lld:pubmed
pubmed-article:10091312pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10091312pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:10091312pubmed:publicationTypeReviewlld:pubmed